Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-17

Clinical Trial Update: Totally Transdermal Sedation in the Weaning From Remifentanil Infusion [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating a totally transdermal sedation approach to facilitate weaning from remifentanil infusion in patients with respiratory insuf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remifentanil (remifentanil)
  • Totally Transdermal Sedation

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Respiratory Insufficiency, Ventilator Weaning | Phase 2 | Status: COMPLETED